Global Intravesical Immunotherapy Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Intravesical Immunotherapy Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Intravesical Immunotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Bacillus Calmette-Guerin (BCG) Therapy
  • 1.2.3 Others
• 1.3 Market by Application
  • 1.3.1 Global Intravesical Immunotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Intravesical Immunotherapy Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Intravesical Immunotherapy Revenue by Region
  • 2.2.1 Global Intravesical Immunotherapy Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Intravesical Immunotherapy Revenue by Region (2019-2024)
  • 2.2.3 Global Intravesical Immunotherapy Revenue by Region (2025-2030)
  • 2.2.4 Global Intravesical Immunotherapy Revenue Market Share by Region (2019-2030)
• 2.3 Global Intravesical Immunotherapy Sales Estimates and Forecasts 2019-2030
• 2.4 Global Intravesical Immunotherapy Sales by Region
  • 2.4.1 Global Intravesical Immunotherapy Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Intravesical Immunotherapy Sales by Region (2019-2024)
  • 2.4.3 Global Intravesical Immunotherapy Sales by Region (2025-2030)
  • 2.4.4 Global Intravesical Immunotherapy Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Intravesical Immunotherapy Sales by Manufacturers
  • 3.1.1 Global Intravesical Immunotherapy Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Intravesical Immunotherapy Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravesical Immunotherapy in 2023
• 3.2 Global Intravesical Immunotherapy Revenue by Manufacturers
  • 3.2.1 Global Intravesical Immunotherapy Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Intravesical Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Intravesical Immunotherapy Revenue in 2023
• 3.3 Global Key Players of Intravesical Immunotherapy, Industry Ranking, 2021 VS 2022
• 3.4 Global Intravesical Immunotherapy Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Intravesical Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Intravesical Immunotherapy, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Intravesical Immunotherapy, Product Offered and Application
• 3.8 Global Key Manufacturers of Intravesical Immunotherapy, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Intravesical Immunotherapy Sales by Type
  • 4.1.1 Global Intravesical Immunotherapy Historical Sales by Type (2019-2024)
  • 4.1.2 Global Intravesical Immunotherapy Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Intravesical Immunotherapy Sales Market Share by Type (2019-2030)
• 4.2 Global Intravesical Immunotherapy Revenue by Type
  • 4.2.1 Global Intravesical Immunotherapy Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Intravesical Immunotherapy Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Intravesical Immunotherapy Revenue Market Share by Type (2019-2030)
• 4.3 Global Intravesical Immunotherapy Price by Type
  • 4.3.1 Global Intravesical Immunotherapy Price by Type (2019-2024)
  • 4.3.2 Global Intravesical Immunotherapy Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Intravesical Immunotherapy Sales by Application
  • 5.1.1 Global Intravesical Immunotherapy Historical Sales by Application (2019-2024)
  • 5.1.2 Global Intravesical Immunotherapy Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Intravesical Immunotherapy Sales Market Share by Application (2019-2030)
• 5.2 Global Intravesical Immunotherapy Revenue by Application
  • 5.2.1 Global Intravesical Immunotherapy Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Intravesical Immunotherapy Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Intravesical Immunotherapy Revenue Market Share by Application (2019-2030)
• 5.3 Global Intravesical Immunotherapy Price by Application
  • 5.3.1 Global Intravesical Immunotherapy Price by Application (2019-2024)
  • 5.3.2 Global Intravesical Immunotherapy Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Intravesical Immunotherapy Market Size by Type
  • 6.1.1 US & Canada Intravesical Immunotherapy Sales by Type (2019-2030)
  • 6.1.2 US & Canada Intravesical Immunotherapy Revenue by Type (2019-2030)
• 6.2 US & Canada Intravesical Immunotherapy Market Size by Application
  • 6.2.1 US & Canada Intravesical Immunotherapy Sales by Application (2019-2030)
  • 6.2.2 US & Canada Intravesical Immunotherapy Revenue by Application (2019-2030)
• 6.3 US & Canada Intravesical Immunotherapy Market Size by Country
  • 6.3.1 US & Canada Intravesical Immunotherapy Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Intravesical Immunotherapy Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Intravesical Immunotherapy Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Intravesical Immunotherapy Market Size by Type
  • 7.1.1 Europe Intravesical Immunotherapy Sales by Type (2019-2030)
  • 7.1.2 Europe Intravesical Immunotherapy Revenue by Type (2019-2030)
• 7.2 Europe Intravesical Immunotherapy Market Size by Application
  • 7.2.1 Europe Intravesical Immunotherapy Sales by Application (2019-2030)
  • 7.2.2 Europe Intravesical Immunotherapy Revenue by Application (2019-2030)
• 7.3 Europe Intravesical Immunotherapy Market Size by Country
  • 7.3.1 Europe Intravesical Immunotherapy Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Intravesical Immunotherapy Revenue by Country (2019-2030)
  • 7.3.3 Europe Intravesical Immunotherapy Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Intravesical Immunotherapy Market Size by Type
  • 8.1.1 China Intravesical Immunotherapy Sales by Type (2019-2030)
  • 8.1.2 China Intravesical Immunotherapy Revenue by Type (2019-2030)
• 8.2 China Intravesical Immunotherapy Market Size by Application
  • 8.2.1 China Intravesical Immunotherapy Sales by Application (2019-2030)
  • 8.2.2 China Intravesical Immunotherapy Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Intravesical Immunotherapy Market Size by Type
  • 9.1.1 Asia Intravesical Immunotherapy Sales by Type (2019-2030)
  • 9.1.2 Asia Intravesical Immunotherapy Revenue by Type (2019-2030)
• 9.2 Asia Intravesical Immunotherapy Market Size by Application
  • 9.2.1 Asia Intravesical Immunotherapy Sales by Application (2019-2030)
  • 9.2.2 Asia Intravesical Immunotherapy Revenue by Application (2019-2030)
• 9.3 Asia Intravesical Immunotherapy Market Size by Region
  • 9.3.1 Asia Intravesical Immunotherapy Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Intravesical Immunotherapy Revenue by Region (2019-2030)
  • 9.3.3 Asia Intravesical Immunotherapy Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Intravesical Immunotherapy Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Intravesical Immunotherapy Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Intravesical Immunotherapy Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Merck
  • 11.1.1 Merck Company Information
  • 11.1.2 Merck Overview
  • 11.1.3 Merck Intravesical Immunotherapy Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Merck Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Merck Recent Developments
• 11.2 Japan BCG Laboratory
  • 11.2.1 Japan BCG Laboratory Company Information
  • 11.2.2 Japan BCG Laboratory Overview
  • 11.2.3 Japan BCG Laboratory Intravesical Immunotherapy Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Japan BCG Laboratory Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Japan BCG Laboratory Recent Developments
• 11.3 China National Biotec
  • 11.3.1 China National Biotec Company Information
  • 11.3.2 China National Biotec Overview
  • 11.3.3 China National Biotec Intravesical Immunotherapy Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 China National Biotec Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 China National Biotec Recent Developments
• 11.4 Serum Institute of India
  • 11.4.1 Serum Institute of India Company Information
  • 11.4.2 Serum Institute of India Overview
  • 11.4.3 Serum Institute of India Intravesical Immunotherapy Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Serum Institute of India Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Serum Institute of India Recent Developments
• 11.5 GSBPL
  • 11.5.1 GSBPL Company Information
  • 11.5.2 GSBPL Overview
  • 11.5.3 GSBPL Intravesical Immunotherapy Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 GSBPL Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 GSBPL Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Intravesical Immunotherapy Industry Chain Analysis
• 12.2 Intravesical Immunotherapy Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Intravesical Immunotherapy Production Mode & Process
• 12.4 Intravesical Immunotherapy Sales and Marketing
  • 12.4.1 Intravesical Immunotherapy Sales Channels
  • 12.4.2 Intravesical Immunotherapy Distributors
• 12.5 Intravesical Immunotherapy Customers

13 Intravesical Immunotherapy Market Dynamics

• 13.1 Intravesical Immunotherapy Industry Trends
• 13.2 Intravesical Immunotherapy Market Drivers
• 13.3 Intravesical Immunotherapy Market Challenges
• 13.4 Intravesical Immunotherapy Market Restraints

14 Key Findings in the Global Intravesical Immunotherapy Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Intravesical Immunotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Bacillus Calmette-Guerin (BCG) Therapy

Table 3. Major Manufacturers of Others

Table 4. Global Intravesical Immunotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Intravesical Immunotherapy Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Intravesical Immunotherapy Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Intravesical Immunotherapy Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Intravesical Immunotherapy Revenue Market Share by Region (2019-2024)

Table 9. Global Intravesical Immunotherapy Revenue Market Share by Region (2025-2030)

Table 10. Global Intravesical Immunotherapy Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Intravesical Immunotherapy Sales by Region (2019-2024) & (K Units)

Table 12. Global Intravesical Immunotherapy Sales by Region (2025-2030) & (K Units)

Table 13. Global Intravesical Immunotherapy Sales Market Share by Region (2019-2024)

Table 14. Global Intravesical Immunotherapy Sales Market Share by Region (2025-2030)

Table 15. Global Intravesical Immunotherapy Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Intravesical Immunotherapy Sales Share by Manufacturers (2019-2024)

Table 17. Global Intravesical Immunotherapy Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Intravesical Immunotherapy Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Intravesical Immunotherapy, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Intravesical Immunotherapy Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Intravesical Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Intravesical Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravesical Immunotherapy as of 2023)

Table 23. Global Key Manufacturers of Intravesical Immunotherapy, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Intravesical Immunotherapy, Product Offered and Application

Table 25. Global Key Manufacturers of Intravesical Immunotherapy, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Intravesical Immunotherapy Sales by Type (2019-2024) & (K Units)

Table 28. Global Intravesical Immunotherapy Sales by Type (2025-2030) & (K Units)

Table 29. Global Intravesical Immunotherapy Sales Share by Type (2019-2024)

Table 30. Global Intravesical Immunotherapy Sales Share by Type (2025-2030)

Table 31. Global Intravesical Immunotherapy Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Intravesical Immunotherapy Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Intravesical Immunotherapy Revenue Share by Type (2019-2024)

Table 34. Global Intravesical Immunotherapy Revenue Share by Type (2025-2030)

Table 35. Intravesical Immunotherapy Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Intravesical Immunotherapy Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Intravesical Immunotherapy Sales by Application (2019-2024) & (K Units)

Table 38. Global Intravesical Immunotherapy Sales by Application (2025-2030) & (K Units)

Table 39. Global Intravesical Immunotherapy Sales Share by Application (2019-2024)

Table 40. Global Intravesical Immunotherapy Sales Share by Application (2025-2030)

Table 41. Global Intravesical Immunotherapy Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Intravesical Immunotherapy Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Intravesical Immunotherapy Revenue Share by Application (2019-2024)

Table 44. Global Intravesical Immunotherapy Revenue Share by Application (2025-2030)

Table 45. Intravesical Immunotherapy Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Intravesical Immunotherapy Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Intravesical Immunotherapy Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Intravesical Immunotherapy Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Intravesical Immunotherapy Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Intravesical Immunotherapy Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Intravesical Immunotherapy Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Intravesical Immunotherapy Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Intravesical Immunotherapy Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Intravesical Immunotherapy Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Intravesical Immunotherapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Intravesical Immunotherapy Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Intravesical Immunotherapy Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Intravesical Immunotherapy Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Intravesical Immunotherapy Sales by Country (2025-2030) & (K Units)

Table 60. Europe Intravesical Immunotherapy Sales by Type (2019-2024) & (K Units)

Table 61. Europe Intravesical Immunotherapy Sales by Type (2025-2030) & (K Units)

Table 62. Europe Intravesical Immunotherapy Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Intravesical Immunotherapy Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Intravesical Immunotherapy Sales by Application (2019-2024) & (K Units)

Table 65. Europe Intravesical Immunotherapy Sales by Application (2025-2030) & (K Units)

Table 66. Europe Intravesical Immunotherapy Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Intravesical Immunotherapy Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Intravesical Immunotherapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Intravesical Immunotherapy Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Intravesical Immunotherapy Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Intravesical Immunotherapy Sales by Country (2019-2024) & (K Units)

Table 72. Europe Intravesical Immunotherapy Sales by Country (2025-2030) & (K Units)

Table 73. China Intravesical Immunotherapy Sales by Type (2019-2024) & (K Units)

Table 74. China Intravesical Immunotherapy Sales by Type (2025-2030) & (K Units)

Table 75. China Intravesical Immunotherapy Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Intravesical Immunotherapy Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Intravesical Immunotherapy Sales by Application (2019-2024) & (K Units)

Table 78. China Intravesical Immunotherapy Sales by Application (2025-2030) & (K Units)

Table 79. China Intravesical Immunotherapy Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Intravesical Immunotherapy Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Intravesical Immunotherapy Sales by Type (2019-2024) & (K Units)

Table 82. Asia Intravesical Immunotherapy Sales by Type (2025-2030) & (K Units)

Table 83. Asia Intravesical Immunotherapy Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Intravesical Immunotherapy Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Intravesical Immunotherapy Sales by Application (2019-2024) & (K Units)

Table 86. Asia Intravesical Immunotherapy Sales by Application (2025-2030) & (K Units)

Table 87. Asia Intravesical Immunotherapy Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Intravesical Immunotherapy Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Intravesical Immunotherapy Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Intravesical Immunotherapy Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Intravesical Immunotherapy Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Intravesical Immunotherapy Sales by Region (2019-2024) & (K Units)

Table 93. Asia Intravesical Immunotherapy Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Intravesical Immunotherapy Sales by Country (2025-2030) & (K Units)

Table 107. Merck Company Information

Table 108. Merck Description and Major Businesses

Table 109. Merck Intravesical Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Merck Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Merck Recent Developments

Table 112. Japan BCG Laboratory Company Information

Table 113. Japan BCG Laboratory Description and Major Businesses

Table 114. Japan BCG Laboratory Intravesical Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Japan BCG Laboratory Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Japan BCG Laboratory Recent Developments

Table 117. China National Biotec Company Information

Table 118. China National Biotec Description and Major Businesses

Table 119. China National Biotec Intravesical Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. China National Biotec Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. China National Biotec Recent Developments

Table 122. Serum Institute of India Company Information

Table 123. Serum Institute of India Description and Major Businesses

Table 124. Serum Institute of India Intravesical Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Serum Institute of India Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Serum Institute of India Recent Developments

Table 127. GSBPL Company Information

Table 128. GSBPL Description and Major Businesses

Table 129. GSBPL Intravesical Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. GSBPL Intravesical Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. GSBPL Recent Developments

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Intravesical Immunotherapy Distributors List

Table 135. Intravesical Immunotherapy Customers List

Table 136. Intravesical Immunotherapy Market Trends

Table 137. Intravesical Immunotherapy Market Drivers

Table 138. Intravesical Immunotherapy Market Challenges

Table 139. Intravesical Immunotherapy Market Restraints

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Intravesical Immunotherapy Product Picture

Figure 2. Global Intravesical Immunotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Intravesical Immunotherapy Market Share by Type: 2023 & 2030

Figure 4. Bacillus Calmette-Guerin (BCG) Therapy Product Picture

Figure 5. Others Product Picture

Figure 6. Global Intravesical Immunotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Intravesical Immunotherapy Market Share by Application: 2023 & 2030

Figure 8. Hospitals

Figure 9. Clinics

Figure 10. Intravesical Immunotherapy Report Years Considered

Figure 11. Global Intravesical Immunotherapy Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 13. Global Intravesical Immunotherapy Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 14. Global Intravesical Immunotherapy Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Intravesical Immunotherapy Revenue Market Share by Region (2019-2030)

Figure 16. Global Intravesical Immunotherapy Sales (2019-2030) & (K Units)

Figure 17. Global Intravesical Immunotherapy Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 18. Global Intravesical Immunotherapy Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Intravesical Immunotherapy Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Intravesical Immunotherapy Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Intravesical Immunotherapy Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Intravesical Immunotherapy Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Intravesical Immunotherapy Sales YoY (2019-2030) & (K Units)

Figure 24. China Intravesical Immunotherapy Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Intravesical Immunotherapy Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Intravesical Immunotherapy Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Intravesical Immunotherapy Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Global Intravesical Immunotherapy Sales Share by Manufacturers (2023)

Figure 30. The Intravesical Immunotherapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. Global Intravesical Immunotherapy Revenue Share by Manufacturers (2023)

Figure 32. The Top 5 and 10 Largest Manufacturers of Intravesical Immunotherapy in the World: Market Share by Intravesical Immunotherapy Revenue in 2023

Figure 33. Global Intravesical Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Intravesical Immunotherapy Sales Market Share by Type (2019-2030)

Figure 35. Global Intravesical Immunotherapy Revenue Market Share by Type (2019-2030)

Figure 36. Global Intravesical Immunotherapy Sales Market Share by Application (2019-2030)

Figure 37. Global Intravesical Immunotherapy Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Intravesical Immunotherapy Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Intravesical Immunotherapy Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Intravesical Immunotherapy Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Intravesical Immunotherapy Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Intravesical Immunotherapy Revenue Share by Country (2019-2030)

Figure 43. US & Canada Intravesical Immunotherapy Sales Share by Country (2019-2030)

Figure 44. US Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Intravesical Immunotherapy Sales Market Share by Type (2019-2030)

Figure 47. Europe Intravesical Immunotherapy Revenue Market Share by Type (2019-2030)

Figure 48. Europe Intravesical Immunotherapy Sales Market Share by Application (2019-2030)

Figure 49. Europe Intravesical Immunotherapy Revenue Market Share by Application (2019-2030)

Figure 50. Europe Intravesical Immunotherapy Revenue Share by Country (2019-2030)

Figure 51. Europe Intravesical Immunotherapy Sales Share by Country (2019-2030)

Figure 52. Germany Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 53. France Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 57. China Intravesical Immunotherapy Sales Market Share by Type (2019-2030)

Figure 58. China Intravesical Immunotherapy Revenue Market Share by Type (2019-2030)

Figure 59. China Intravesical Immunotherapy Sales Market Share by Application (2019-2030)

Figure 60. China Intravesical Immunotherapy Revenue Market Share by Application (2019-2030)

Figure 61. Asia Intravesical Immunotherapy Sales Market Share by Type (2019-2030)

Figure 62. Asia Intravesical Immunotherapy Revenue Market Share by Type (2019-2030)

Figure 63. Asia Intravesical Immunotherapy Sales Market Share by Application (2019-2030)

Figure 64. Asia Intravesical Immunotherapy Revenue Market Share by Application (2019-2030)

Figure 65. Asia Intravesical Immunotherapy Revenue Share by Region (2019-2030)

Figure 66. Asia Intravesical Immunotherapy Sales Share by Region (2019-2030)

Figure 67. Japan Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 71. India Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 72. Australia Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 73. Middle East, Africa and Latin America Intravesical Immunotherapy Sales Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Intravesical Immunotherapy Sales Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Intravesical Immunotherapy Revenue Share by Country (2019-2030)

Figure 78. Middle East, Africa and Latin America Intravesical Immunotherapy Sales Share by Country (2019-2030)

Figure 79. Brazil Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 80. Mexico Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 81. Turkey Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 82. Israel Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 83. GCC Countries Intravesical Immunotherapy Revenue (2019-2030) & (US$ Million)

Figure 84. Intravesical Immunotherapy Value Chain

Figure 85. Intravesical Immunotherapy Production Process

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed